Drugs suppressing transcytosis in brain endothelial cells such as the protein kinase inhibitor imatinib have been shown to improve outcomes in ECM, as well as in experimental and human stroke (39, 40, 41, 42, 43). The gene discussed is WEE1; the disease is Stroke.